This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Transforming imaging data into actionable predictions
Our Platform
We have built a cloud-based, tissue-agnostic platform in order to extract key radiomics drivers from the world’s largest imaging data registries.
Discover our platforms
-
Data security by design
Quibim is ISO27001 certified. Information is encrypted during storage, transfer and at file-level. Data processing and storage are in compliance with HIPAA and GDPR. Microsoft Azure’s cloud platform provides secure and unlimited data storage. -
Imaging Data management and harmonization
QP-Insights® is a one-stop-shop platform that handles, indexes, stores, and harmonizes imaging data, generating a standardized image quality that minimizes variability in image signal, contrast and noise across equipment manufacturers. Furthermore, QP-Insights® links imaging data with EHR information and other multi-omics techniques. -
Image analysis
Automated extraction of radiomics and deep features for clinical research and the discovery of new imaging biomarkers.
-
0 +Sites working with Quibim platforms worldwide
-
0 +De-identified cancer patients registry
-
0 M+De-identified research imaging data
Life Sciences
We build value-based partnerships with biopharma companies and real-world, evidence-driven teams to accelerate drug development programs. We help to identify candidates for clinical studies or patients more likely to respond to a drug, monitoring toxicity and adverse events through AI models.
Discover our case studies
-
![Image 02 pediatric oncology CS]()
Empowering DIPG and Neuroblastoma through advanced imaging biomarkers
Read more
-
![Image 02 Predict metastasis prostate cancer CS]()
Prediction of metastatic relapse in intermediate/high risk localized prostate cancer patients from staging medical images and clinical variables
Read more
-
![Image 03 DLBCL CS]()
Prognostic value of genetic alterations and 18F-FDG PET/CT imaging features in diffuse large B cell lymphoma
Read more
Products
We create best-in-class software as a medical device for healthcare providers.
Discover our products
-
![Qp-prostate-grey]()
QP-Prostate®
Streamline your clinical practice with an AI solution that integrates effortlessly with your PACS system. QP-Prostate® revolutionizes the prostate MRI read by facilitating the work of radiologists. It provides precise, quantitative information and automates tasks, resulting in improved and standardized decision-making. Our technology ensures PI-RADS compliance and optimizes input data for detailed interpretation.Learn more -
![QP-Brain-grey]()
QP-Brain®
Accelerate Brain Diagnosis with QP-Brain® The Innovative Approach to Volumetrics and White Matter Hyperintensity (WMH) Analysis. QP-Brain® transforms diagnosis with objective analysis. The brain volumetry tool provides precise volume and morphometry calculations to support disease classification and progression. The WMH tool characterizes white matter hyperintensities through advanced imaging calculations. Upgrade your diagnostic process with QP-Brain®Learn more
Latest news
-
![230728_Hepatitis5]()
Unlocking Predictive Insights: Genetic and Imaging Features in Diffuse Large B Cell Lymphoma (DLBCL).
Read more
-
![MicrosoftTeams-image (53)]()
Imaging Biomarker Panels: setting a new paradigm in oncologic patient care .
Read more
-
![imaging biobanks]()
Empowering communities with imaging biobanks: the path to accessible personalized medicine for all
Read more